Vineet Laboratories Ltd
Vineet Laboratories Ltd (VINEETLAB) last reported results for the quarter ended Mar 2026, with sales of ₹18.89 crore and net profit of ₹0.73 crore. Vineet Laboratories Ltd’s annual general meeting is scheduled for 30 Nov 2026. The stock last traded at ₹36.5, a market capitalisation of ₹70.1 crore, on a P/E of 63.2. Over the past 52 weeks the stock has ranged between ₹28 and ₹43.8. Figures are as of 6 Oct 2026 and are not real time.
Vineet Laboratories Ltd share price and key metrics
- Current price
- ₹36.5
- Market cap
- ₹70.1 cr
- Stock P/E
- 63.2
- Book value
- ₹23.8
- ROE
- 3.68%
- ROCE
- 8.49%
- Dividend yield
- 0.00%
- 52w high / low
- 43.8/28.0
Metrics as of 6 Oct 2026. Not real time.
Track Vineet Laboratories Ltd
Cruxal reads every Vineet Laboratories Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Vineet Laboratories Ltd growth and returns
- 10 Years
- %
- 5 Years
- -25%
- 3 Years
- -35%
- TTM
- -21%
- 10 Years
- %
- 5 Years
- -9%
- 3 Years
- -4%
- TTM
- 105%
- 10 Years
- %
- 5 Years
- -11%
- 3 Years
- -4%
- 1 Year
- 5%
- 10 Years
- %
- 5 Years
- -8%
- 3 Years
- -23%
- Last Year
- 4%
Vineet Laboratories Ltd quarterly results
In the quarter ended Mar 2026, sales were ₹18.89 cr, up 34.2% from ₹14.08 cr a year earlier. Net profit turned positive at ₹0.73 cr.
| ₹ crore | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 23.86 | 18.96 | 18.1 | 14.08 | 7.44 | 17.42 | 15.65 | 18.89 |
| Expenses | 24.65 | 19.27 | 22.23 | 25.12 | 7.13 | 14.24 | 13.17 | 16.4 |
| Operating profit | -0.79 | -0.31 | -4.13 | -11.04 | 0.31 | 3.18 | 2.48 | 2.49 |
| OPM % | -3.31% | -1.64% | -22.82% | -78.41% | 4.17% | 18.25% | 15.85% | 13.18% |
| Other income | 0.37 | 0.2 | 0.03 | 1.38 | 0.02 | 0.01 | 0.05 | 0.03 |
| Interest | 1.14 | 0.99 | 0.95 | 0.9 | 0.61 | 2.19 | 1.09 | 0.99 |
| Depreciation | 0.61 | 0.62 | 0.62 | 0.66 | 0.63 | 0.63 | 0.63 | 0.54 |
| Profit before tax | -2.17 | -1.72 | -5.67 | -11.22 | -0.91 | 0.37 | 0.81 | 0.99 |
| Tax % | -1.84% | 6.98% | 0.53% | -6.24% | -4.40% | -8.11% | -3.70% | 27.27% |
| Net profit | -2.13 | -1.83 | -5.71 | -10.53 | -0.87 | 0.4 | 0.85 | 0.73 |
| EPS (₹) | -1.11 | -0.95 | -2.97 | -5.48 | -0.45 | 0.21 | 0.44 | 0.38 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Vineet Laboratories Ltd annual results
| ₹ crore | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Sales | -0 | 243 | 191 | 212 | 151 | 75 | 59.4 |
| Operating profit | -0.01 | 8.15 | 13.16 | 7.66 | 7.2 | -16.28 | 8.49 |
| OPM % | — | 3.35% | 6.89% | 3.61% | 4.78% | -21.71% | 14.29% |
| Net profit | -0.01 | 1.78 | 6.64 | 1.25 | 1.03 | -20.19 | 1.11 |
| EPS (₹) | -0.11 | 0.93 | 3.46 | 0.65 | 0.54 | -10.52 | 0.58 |
TTM is the trailing twelve months to the most recent quarter.
Vineet Laboratories Ltd balance sheet
| ₹ crore | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Equity capital | 0.41 | 9.22 | 9.22 | 9.22 | 9.22 | 9.22 | 19.21 |
| Reserves | -0.01 | 17.40 | 24.00 | 24.46 | 25.51 | 5.43 | 26.40 |
| Borrowings | -0.00 | 12.48 | 26.51 | 31.09 | 44.30 | 40.05 | 45.33 |
| Other liabilities | -0.00 | 69.64 | 73.59 | 51.08 | 37.84 | 39.84 | 33.84 |
| Total liabilities | 0.40 | 108.74 | 133.32 | 115.85 | 116.87 | 94.54 | 124.78 |
| Fixed assets | -0.00 | 19.67 | 21.38 | 26.65 | 26.92 | 25.46 | 24.24 |
| CWIP | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| Investments | -0.00 | 0.12 | 0.14 | 0.13 | 0.18 | 0.21 | 0.19 |
| Other assets | 0.40 | 88.95 | 111.80 | 89.07 | 89.77 | 68.87 | 100.35 |
| Total assets | 0.40 | 108.74 | 133.32 | 115.85 | 116.87 | 94.54 | 124.78 |
As reported by the company. Total assets equal total liabilities by construction.
Vineet Laboratories Ltd cash flow
| ₹ crore | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Cash from operations | -0.00 | 27.49 | 7.63 | -9.62 | -6.61 | 11.49 | -12.03 |
| Cash from investing | -0.00 | -7.81 | -3.68 | -6.69 | -2.22 | -3.18 | -1.11 |
| Cash from financing | -0.00 | 18.62 | 11.96 | 0.27 | 8.43 | -8.23 | 29.74 |
| Net cash flow | -0.00 | 38.30 | 15.91 | -16.03 | -0.40 | 0.08 | 16.60 |
| Free cash flow | -0.00 | 27.49 | 7.63 | -17.25 | -9.40 | 10.44 | -13.23 |
| CFO / operating profit | -0% | 327% | 82% | -87% | -88% | -71% | -144% |
Negative figures are outflows. CFO / operating profit is a ratio, not an amount.
Vineet Laboratories Ltd operating ratios
| Per year | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| ROCE % | 34.08% | 23.13% | 8.69% | 6.65% | -27.95% | 8.49% |
| Debtor days | 64.03 | 69.14 | 60.45 | 76.59 | 64.48 | 70.05 |
| Inventory days | 73.12 | 109.19 | 97.79 | 158.26 | 259.67 | 606.03 |
| Days payable | 114.08 | 161.20 | 73.90 | 103.37 | 174.65 | 239.52 |
| Cash conversion cycle | 23.07 | 17.13 | 84.34 | 131.48 | 149.50 | 436.56 |
| Working capital days | 14.41 | -19.46 | 20.63 | 28.48 | -37.28 | 88.98 |
Ratios as computed by the source from the reported statements. Rows a company does not report are omitted.
Vineet Laboratories Ltd shareholding pattern
Promoters held 5.98% at Jun 2026, down from 29.26% at Jun 2025. FIIs 0.50%.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 36.07% | 35.85% | 35.85% | 29.26% | 15.89% | 12.46% | 5.98% | 5.98% |
| FIIs | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.36% | 0.50% |
| Public | 63.93% | 64.15% | 64.15% | 70.74% | 84.11% | 87.54% | 93.67% | 93.52% |
| No. of shareholders | 10,300 | 10,058 | 10,025 | 9,988 | 9,682 | 10,003 | 9,929 | 9,901 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
When is Vineet Laboratories Ltd’s AGM?
Vineet Laboratories Ltd’s annual general meeting is scheduled for 30 Nov 2026.
- AGMExtension of time for holding the 10th Annual General Meeting
See the full results calendar for every Indian company reporting in the next 30 days.
Vineet Laboratories Ltd corporate filings
- Vineet Laboratories Reports Clarification of Clerical Error in FY2026 Financials, No Material Impact ConfirmedCompany Updatemedium impact
Cruxal's analysis: Vineet Laboratories Limited has issued a clarification regarding a clerical/typographical…
Read the full analysis - Vineet Laboratories Limited Resigns Statutory Auditor NSVR & Associates LLP, Indicating Potential Corporate Governance and Audit Process ChangesCompany Updatemedium impact
Cruxal's analysis: Vineet Laboratories Limited has officially announced the resignation of its statutory…
Read the full analysis - The Trading window for dealing in the securities of the Company will remain closed form 01st October, 2026 till 48 hours after the announcement of Standalone Un-audited Financial Results ....Insider Trading / SASTlow impact
- Vineet Laboratories Ltd receives two-month extension from ROC for 10th AGMCompany Updatelow impact
Cruxal's analysis: The Registrar of Companies (ROC), Hyderabad, has granted Vineet Laboratories Ltd a…
Read the full analysis - Vineet Laboratories Limited corrects typographical error in FY26 audited financial results disclosureResultlow impact
Cruxal's analysis: Vineet Laboratories Limited has issued a clarification regarding a typographical error in…
Read the full analysis - Vineet Laboratories reports turnaround to profit in FY26 with INR 1.11 crore net profit, supported by equity infusionBoard Meetinghigh impact
Cruxal's analysis: Vineet Laboratories Limited has reported a financial turnaround for the fiscal year ended…
Read the full analysis - Vineet Laboratories Limited schedules Board Meeting for August 25, 2026, to approve Audited Financial Results for Q4 and FY26Board Meetinglow impact
Cruxal's analysis: Vineet Laboratories Limited has issued a formal intimation regarding a Board of Directors…
Read the full analysis - Vineet Laboratories Ltd releases CRISIL Monitoring Agency Report for quarter ended June 30, 2026Company Updatelow impact
Cruxal's analysis: Vineet Laboratories has filed the Monitoring Agency Report issued by CRISIL Ratings…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.